Shanghai Haohai Biological Technology Co Ltd 2017 SR
The report highlights Shanghai Haohai Biological Technology Co., Ltd.'s performance in 2017, focusing on its strategic expansion in the ophthalmology sector and its inclusion in the National Enterprise Technology Centers list. The company achieved a 58.0% increase in aggregate revenue and significantly increased its R&D investment to RMB 76.33 million. Environmental efforts included maintaining ISO 14001 certification and implementing measures to reduce packaging volumes for rhEGF products. Socially, the company grew its workforce to 1,107 employees and continued supporting cataract surgeries through charitable partnerships like Lifeline Express.
Company: Shanghai Haohai Biological Technology Co Ltd
Sector: Manufacturing
Country: China
Year: 2017
Type: SR
Pages: 45
Shanghai Haohai Biological Technology Co Ltd
The report highlights Shanghai Haohai Biological Technology Co., Ltd.'s performance in 2017, focusing on its strategic expansion in the ophthalmology sector and its inclusion in the National Enterprise Technology Centers list. The company achieved a 58.0% increase in aggregate revenue and significantly increased its R&D investment to RMB 76.33 million. Environmental efforts included maintaining ISO 14001 certification and implementing measures to reduce packaging volumes for rhEGF products. Socially, the company grew its workforce to 1,107 employees and continued supporting cataract surgeries through charitable partnerships like Lifeline Express.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Jan 1, 2017 - Dec 31, 2017
Fiscal Year
2017
Published
Jun 11, 2018
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees